GlobalData

Vaccine developers are selecting manufacturers that are closer to their homes, which could be due to storage or manufacturing…

Most contract manufacturing service agreements are for recombinant vector vaccines, followed by subunit vaccines

T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents

While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will…

Social media and cloud computing became the most dominant technologies for current investments for pharma in 2020

Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months

Three major deals contributes 72 per cent of total deal value

The success of digital transformation will heavily depend on employees being on board and adapting as digital transformation…

The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…

The COVID-19 halo effect is driving extra funding to many small pharma companies, especially those in the infectious disease space